OUP (Osage University Partners) vs RA Capital
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| OUP (Osage University Partners) | RA Capital | |
|---|---|---|
| Type | Venture capital | Venture capital |
| HQ | Bala Cynwyd | Boston |
| Founded | 2009 | 2002 |
| Check size | $1M – $20M | — |
| Stages | Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage | Seed, Series A, Series B, Series C, Late Stage |
| Sectors | AI & Machine Learning, Biotech, Cleantech, Climate Tech, Cloud Computing, Cybersecurity, Deep Tech, Digital Health, Energy, Enterprise Software, Hardware, Healthtech, Medical Devices, New Materials, Quantum Computing, SaaS, Sector Agnostic, Semiconductors | Biotech, Medical Devices |
| AUM | $800M | $16.4B |
| Tracked investments | 118 | 233 |
| Exits (acquired/public) | 1 | 3 |
| Led rounds on record | — | 4 |
| Dated deals, last 24 mo | 3 | 11 |
Shared portfolio · 5
Precision BioSciencesSpero TherapeuticsSynthorxAerovate TherapeuticsVor Biopharma
Frequently asked questions
- Do OUP (Osage University Partners) and RA Capital invest together?
- Yes — OUP (Osage University Partners) and RA Capital appear together in 5 tracked portfolio companies, including Precision BioSciences, Spero Therapeutics, Synthorx, Aerovate Therapeutics, Vor Biopharma.